Alvogen
Setting a new standard for the future of pharma
Company
Who we are
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 35 markets, Alvogen’s key regions include the U.S. and emerging markets in the CEE and APAC regions.
Products
Targeted portfolio
Alvogen's product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, neurology and gastroenterology, in addition to a fast-growing portfolio of biosimilars, brands and OTC products.
Purpose
Making people´s lives better
Our true purpose as a company is to make people's lives better by producing high quality medicines that help people live longer, healthier and more active lives and making them more accessible to those who might not otherwise be able to afford them.
Leadership team
Meet our CEO
Robert Wessman‘s business plan for Alvogen was originally scribbled on a napkin in a New York restaurant back in 2009 in the middle of one of the worst financial crises in history when access to capital was virtually non-existent.
Newsroom
Latest news and initiatives
Follow news and programs from Alvogen around the world as they unfold.
Worldwide
Worldwide offices
Alvogen has commercial operations in 35 countries, with regional hubs, manufacturing and R&D capabilities in the U.S., South Korea and Romania.
We use cookies to ensure our website works properly and to collect statistics about users in order for us to improve the website. Learn more.